Kevin Caliendo
Stock Analyst at UBS
(4.15)
# 1,542
Out of 4,520 analysts
381
Total ratings
58.3%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintained: Buy | $100 → $115 | $107.47 | +7.01% | 33 | Jun 8, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $6 | $9.43 | -36.37% | 16 | May 15, 2026 | |
| ACH Accendra Health | Rated: Hold | $3 → $4.5 | $3.47 | +29.68% | 19 | May 12, 2026 | |
| MCK McKesson | Maintained: Buy | $1,000 → $1,050 | $841.39 | +24.79% | 32 | May 8, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $5.81 | -13.94% | 8 | May 8, 2026 | |
| LFST LifeStance Health Group | Maintained: Buy | $12 → $13 | $11.58 | +12.26% | 15 | May 8, 2026 | |
| COR Cencora | Maintained: Buy | $415 → $412 | $307.90 | +33.81% | 26 | May 7, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Buy | $18 → $17 | $14.05 | +21.00% | 20 | May 7, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $87 → $85 | $87.82 | -3.21% | 9 | May 6, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $15 → $14 | $10.96 | +27.74% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $78 | $81.31 | -4.07% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $185 → $186 | $176.76 | +5.23% | 25 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 → $37 | $22.27 | +66.14% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $210 → $220 | $210.68 | +4.42% | 18 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $2 | $3.14 | -36.31% | 8 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $57 | $39.79 | +43.25% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $375 | $281.45 | +33.24% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 → $260 | $228.52 | +13.78% | 22 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $25 | $26.74 | -6.51% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $20.60 | -12.62% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 → $320 | $283.36 | +12.93% | 20 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 → $180 | $225.37 | -20.13% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $9 | $13.23 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $250 → $285 | $400.00 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $72 → $79 | $66.44 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $426.09 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $595 → $610 | $373.11 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $180 → $175 | $253.04 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.44 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $32.03 | n/a | 5 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $8 | $4.90 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $115.41 | n/a | 1 | Jan 30, 2018 |
CVS Health
Jun 8, 2026
Maintained: Buy
Price Target: $100 → $115
Current: $107.47
Upside: +7.01%
Teladoc Health
May 15, 2026
Maintained: Hold
Price Target: $6
Current: $9.43
Upside: -36.37%
Accendra Health
May 12, 2026
Rated: Hold
Price Target: $3 → $4.5
Current: $3.47
Upside: +29.68%
McKesson
May 8, 2026
Maintained: Buy
Price Target: $1,000 → $1,050
Current: $841.39
Upside: +24.79%
Evolent Health
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $5.81
Upside: -13.94%
LifeStance Health Group
May 8, 2026
Maintained: Buy
Price Target: $12 → $13
Current: $11.58
Upside: +12.26%
Cencora
May 7, 2026
Maintained: Buy
Price Target: $415 → $412
Current: $307.90
Upside: +33.81%
DENTSPLY SIRONA
May 7, 2026
Maintained: Buy
Price Target: $18 → $17
Current: $14.05
Upside: +21.00%
Henry Schein
May 6, 2026
Maintained: Hold
Price Target: $87 → $85
Current: $87.82
Upside: -3.21%
AdaptHealth
May 6, 2026
Maintained: Buy
Price Target: $15 → $14
Current: $10.96
Upside: +27.74%
May 6, 2026
Maintained: Hold
Price Target: $82 → $78
Current: $81.31
Upside: -4.07%
May 1, 2026
Maintained: Hold
Price Target: $185 → $186
Current: $176.76
Upside: +5.23%
Apr 30, 2026
Maintained: Buy
Price Target: $41 → $37
Current: $22.27
Upside: +66.14%
Apr 22, 2026
Maintained: Hold
Price Target: $210 → $220
Current: $210.68
Upside: +4.42%
Feb 27, 2026
Maintained: Hold
Price Target: $4 → $2
Current: $3.14
Upside: -36.31%
Feb 26, 2026
Maintained: Buy
Price Target: $48 → $57
Current: $39.79
Upside: +43.25%
Feb 9, 2026
Maintained: Buy
Price Target: $390 → $375
Current: $281.45
Upside: +33.24%
Feb 6, 2026
Maintained: Buy
Price Target: $220 → $260
Current: $228.52
Upside: +13.78%
Feb 3, 2026
Maintained: Hold
Price Target: $22 → $25
Current: $26.74
Upside: -6.51%
Oct 31, 2025
Maintained: Hold
Price Target: $17 → $18
Current: $20.60
Upside: -12.62%
Oct 29, 2025
Maintained: Buy
Price Target: $325 → $320
Current: $283.36
Upside: +12.93%
Jul 25, 2025
Maintained: Hold
Price Target: $374 → $180
Current: $225.37
Upside: -20.13%
May 8, 2025
Maintained: Hold
Price Target: $12 → $9
Current: $13.23
Upside: n/a
Feb 24, 2025
Maintained: Hold
Price Target: $250 → $285
Current: $400.00
Upside: n/a
Dec 21, 2023
Maintained: Hold
Price Target: $72 → $79
Current: $66.44
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $426.09
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $595 → $610
Current: $373.11
Upside: n/a
Oct 3, 2022
Maintained: Hold
Price Target: $180 → $175
Current: $253.04
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $16.44
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: $11 → $10
Current: $32.03
Upside: n/a
Mar 3, 2020
Maintained: Hold
Price Target: $12 → $8
Current: $4.90
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $115.41
Upside: n/a